Literature DB >> 2841027

Control of human T-lymphocyte interleukin-2 production by a cAMP-dependent pathway.

L E Averill1, R L Stein, G M Kammer.   

Abstract

Cyclic AMP has long been proposed to be the intracellular second messenger that conveys the inhibitory signal for T-cell activation and clonal T-cell proliferation. The present study further explores the mechanism by which the cAMP pathway regulates human T-lymphocyte interleukin-2 (IL-2) production and T-cell blastogenesis. Activation of adenylate cyclase, inhibition of cAMP-dependent phosphodiesterase, or the direct addition of the cell-permeable cAMP analog, 8-N3-cAMP, increased occupancy of intracellular cAMP receptors, inhibited IL-2 production, and reduced T-cell proliferation. However, inhibition of cAMP-dependent protein phosphorylation by N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide (H-8), a cell-permeable inhibitor of cyclic nucleotide-dependent protein kinase, partially restored IL-2 production. Our data support the conclusion that the cAMP pathway conveys an inhibitory signal for IL-2 production and T-cell proliferation via an integral protein phosphorylation step.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841027     DOI: 10.1016/0008-8749(88)90164-5

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  11 in total

1.  In vitro exposure to the herbicide atrazine inhibits T cell activation, proliferation, and cytokine production and significantly increases the frequency of Foxp3+ regulatory T cells.

Authors:  Lindsay E Thueson; Tiffany R Emmons; Dianna L Browning; Joanna M Kreitinger; David M Shepherd; Scott A Wetzel
Journal:  Toxicol Sci       Date:  2014-11-28       Impact factor: 4.849

2.  Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2.

Authors:  M A Giembycz; C J Corrigan; J Seybold; R Newton; P J Barnes
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

3.  Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus.

Authors:  P Hasler; L A Schultz; G M Kammer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Activation of protein kinase C via the T-cell receptor complex potentiates cyclic AMP responses in T-cells.

Authors:  A Kvanta; C Nordstedt; M Jondal; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

5.  Multiple cAMP-induced signaling cascades regulate prolactin expression in T cells.

Authors:  S Gerlo; P Verdood; E L Hooghe-Peters; R Kooijman
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

6.  IL-2 regulation of soluble IL-2 receptor levels following thermal injury.

Authors:  J A Teodorczyk-Injeyan; B G Sparkes; S Lalani; W J Peters; G B Mills
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

7.  Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes.

Authors:  G M Kammer; I U Khan; C J Malemud
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

8.  Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation and interleukin-2 secretion by physiologic combinations of dexamethasone and prostaglandin E2.

Authors:  L Elliott; W Brooks; T Roszman
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046

9.  Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection.

Authors:  Mohammad-Ali Jenabian; Nabila Seddiki; Ahmad Yatim; Matthieu Carriere; Anne Hulin; Mehwish Younas; Elnaz Ghadimi; Ayrin Kök; Jean-Pierre Routy; Alain Tremblay; Jean Sévigny; Jean-Daniel Lelievre; Yves Levy
Journal:  PLoS Pathog       Date:  2013-04-25       Impact factor: 6.823

10.  Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles.

Authors:  D Chen; E V Rothenberg
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.